Drug Resistance - Research reports on drug resistance from Cubist Pharmaceuticals provide new insights
Life Sciences - Findings from J.G Robertson and co-researchers advance knowledge in life sciences
Life Sciences - Reports outline life sciences study findings from M. Levina and colleagues
Life Sciences - Study data from M. Walden and co-authors update knowledge of life sciences
Pneumonia Therapy - New findings from Pfizer Inc. in the area of pneumonia therapy described
Acute Tonsillitis - Data on acute tonsillitis detailed by researchers at University of Newcastle
Asthma - New asthma research from University of Utah outlined
Dysphagia - Research from University of Rostock has provided new data on dysphagia
Escherichia Coli - Findings in Escherichia coli reported from M.V. Selma and co-researchers
Escherichia Coli - New Escherichia coli study findings have been reported by M. Lenahan and colleagues
Hepatitis - Research on hepatitis reported by scientists at Tokyo University
Legionnaire Disease - Researchers from University of Leuven report recent findings in legionnaire disease
Marketing and Licensing Agreements - Research conducted at S.A. Otchere and co-researchers has updated our knowledge about marketing and licensing agreements
Obstetrics - Study findings on obstetrics are outlined in reports from P. Renaudin and colleagues
Regulatory Actions - Studies from T. Obrien and colleagues provide new data on regulatory actions
Social Science - Research from University of Sheffield yields new findings on social science
Type 1 Diabetes - New type 1 diabetes study findings have been reported by M. Gimenez and colleagues
Vaccines - Research on vaccines detailed by scientists at Tulane University
West Nile Virus - Research from University of Queensland yields new findings on west nile virus
Angioplasty - Research findings from University Medical Center, Division of Vascular Surgery update understanding of angioplasty
Anthrax - Studies from Purdue University, Department of Biological Sciences reveal new findings on anthrax
Anthrax Therapy - Investigators at Institute Pasteur target anthrax therapy
Anthrax Vaccines - Studies from University of California, Moores Cancer Center further understanding of anthrax vaccines
DNA Vaccines - Findings from Oregon State University, Department of Pharmaceutical Sciences broaden understanding of DNA vaccines
DNA Vaccines - Studies from National Institute of Allergy and Infectious Disease update current data on DNA vaccines
Enzyme Research - New enzyme research study findings reported from Gunma Prefectural Institute of Public Health and Environmental Sciences
Hyperparathyroidism Therapy - Research from University Hospital yields new data on hyperparathyroidism therapy
Legionnaire Disease Genetics - Research from Kyushu University, Faculty of Medical Sciences in legionnaire disease genetics provides new insights
Life Sciences - Data on pediatric in children published by researchers at Ramathibodi Hospital, Department of Pediatrics
Life Sciences - Hokkaido Institute of Public Health reports research in life sciences
Life Sciences - New findings reported from National Institute of Public Health describe advances in life sciences
Life Sciences - Report summarizes life sciences study findings from Katholieke University Leuven, Rega Institute for Medical Research
Life Sciences - Reports summarize pediatric in children research from Institute of Public Health
Life Sciences - Researchers at Szent Istvan University target life sciences
Myelodysplastic Syndrome Therapy - Researchers from University of South Florida, H. Lee Moffitt Cancer Center discuss findings in myelodysplastic syndrome therapy
Personality Disorders Genetics - New findings from Norwegian Institute of Public Health in the area of personality disorders genetics described
Rhabdomyolysis Therapy - Research reports from Tufts University, Molecular Cardiology Research Institute provide new insights into rhabdomyolysis therapy
Toxicology - Studies from National Institute of Health Research add new findings in the area of toxicology
Trachoma - New trachoma study findings have been reported by K. Quint and colleagues
Vaccines - Reports outline vaccines study results from Institute of Microbiology and Epidemiology
West Nile Virus Epidemiology - Study findings on west nile virus epidemiology are outlined in reports from J.A. Dennett and colleagues
Adverse Drug Reactions - CollaGenex Pharmaceuticals Announces Results of Phase 4 Clinical Study Showing Oracea Equally Effective as 100 mg Doxycycline in Treatment of Rosacea
Adverse Drug Reactions - DrugLogic(R), Inc. Announces Integrated VAERS/AERS Workflow Solution
Asthma - ALVESCO(R) Gains FDA Approval for the U.S. Market
Batten Disease - StemCells, Inc. Provides Batten's Clinical Trial Update
Biotechnology Business - Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
Bone Research - Orthovita Submits 510(k) Application to FDA for the Use of CORTOSS(R) Bone Augmentation Material in Vertebral Augmentation
Breast Implants - Silicone Breast Implants Making a Comeback
Cancer - BioDelivery Sciences and Meda to Expand Clinical Development Program for BEMA(TM) Fentanyl
Cancer - BSD-2000 Hyperthermia System Acquired by Long Beach Memorial Medical Center
Cancer - Soviets Took Probiotics to the Next Level, Say Researchers at U.S. Probiotic Firm
Cancer Gene Therapy - Children's Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis
Cardiology - Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
Cloning - Animal Protection Groups Condemn FDA's Endorsement of Animal Cloning
Colitis - VGX Pharmaceuticals receives FDA clearance to commence clinical trials of VGX-1027, a novel oral drug with potent anti-inflammatory activity
Colon Cancer - EXACT Sciences Schedules Meeting with CMS to Discuss Application for National Coverage of Stool-based DNA Colorectal Cancer Screening
Consumer Healthcare Products Association - CHPA Lends Support to FDA's Announcement Against Use of Oral, Over-the-Counter Cough and Cold Medicines in Children Under Two
Crohn Disease - FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
Drug Development - Physician-scientist urges improved drug regulation to ensure heart safety of non-heart drugs
Enzyme Research - FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical (Recombinant)
Epilepsy - Keppra XR(TM) Extended-Release Tablets Filed with the FDA
Gene Therapy - Clinical Trial to Treat Rare Skin Disorder With siRNA Technology
Headache and Migraine - MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
Hematology - Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
Hepatitis C Virus - Roche responds to announcement of 'IDEAL' hepatitis C trial results
HIV/AIDS - Progenics Initiates Phase 2 Clinical Trials for PRO 140, a Novel HIV Antibody Therapy
Homeopathy - FDA to Declare Cold Medicines Too Risky, Homeopathy Offers a Safe Alternative
Homeopathy - Healthcare Business Launched by Branson will Include Homeopathy
Liver Cancer - CELSION Secures Special Protocol Assessment of its Pivotal Phase III Liver Cancer Trial from FDA
Mesothelioma - Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
Midwest BioResearch LLC - Midwest BioResearch Hires Former FDA Investigator James Plucinski to Guide Client Quality Assurance
Mucositis - Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Non-Small Cell Lung Cancer - Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
Obesity and Diabetes - New Dimensions Weight Loss Surgery Among First to Offer REALIZE(TM) Personalized Banding Solution
Pelvic Exam - Increased Usage of Mifeprex(R) Helps Slow Decline in Abortion Providers
Pharmacokinetics - NitroMed Reports on BiDil XR(TM) Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil(R) Sales Force, and Retains Investment Bank to Advise on Strategic Options
Pneumonia - Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
POZEN Inc. - POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
PreMD Inc. - PreMD Announces FDA Decision on POC Skin Cholesterol Test
Prostate Cancer - Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Regulatory Actions - ADVENTRX Announces ANX-530 Safety Data and Provides NDA Submission Guidance
Regulatory Actions - Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
Regulatory Actions - Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook
Regulatory Actions - Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
Research and Markets - Veterinary Diagnostics and Equipment Global Market Report Is Available Now
Smiths Medical - Smiths Medical Receives FDA Clearance for Expansion of Power Injectable Port Line Including a New Arm Port
St. Jude Medical, Inc. - St. Jude Medical Announces U.S. Clearance for Cardiac Image Integration Software
Start Licensing, Inc. - Start Licensing, Inc. Welcomes FDA's Finding of Safety of Food From Cloned Animals
